Post by
antoninus on Aug 04, 2010 10:07am
now is the time
now is the time to push forward on finding a partner for TX....this IS the main driver of this company....it NEVER was uveitis...it was ALWAYS transplant. When is this company going to go and find a suitable partner for TX? and what of psoriasis????
you see, because these other indications were sidelined while uveitis became the darling, we are now VULNERABLE.
My gut tells me that someone involved in TX is fully aware of this development, and WILL look at us not necessarily as a partner, but as a TAKEOVER....i mean, for a paltry sum, someone could take this whole drug, lock stock and barrel out for what? 50, 60 million or less?
and by the way, how is it that a few outstanding issues have turned into a whole new trial? could the fda have been swayed by say a giant pharma in the TX field?